Given the incomplete current understanding of these neoplasms, we suggest that all uterine mesenchymal neoplasms with overlapping morphology and immunophenotype between endometrial stromal and smooth muscle neoplasms undergo molecular testing to identify a KAT6B/A::KANSL1 fusion. Here, KAT6B is linked to neoplasm.